Danaher Corporation (DHR) Stock Price & AI Analysis

$197.14
$0.65
(0.33%)
Life Sciences Tools & Services

NYSE USA

April 27, 4:16 PM EDT
  • Market Cap.
    141.09B
  • Volume
    2.61M
  • Avg. Volume
    4.96M
  • Target Price
    $244.78
  • 52W Range
    171.00 - 281.70
  • RSI (14)
    51.02
  • Beta
    0.81
  • PEG Ratio
    4.64
  • SMA 20
    2.68%
  • SMA 50
    -2.45%
  • SMA 200
    -17.43%
  • Insider Owner
    9.35%
  • Insider Trans
    -0.06%
  • Institution Owner
    81.27%
  • Institution Trans
    0.05%
  • Short Interest
    6.03%
  • EPS next Y
    11.31

Danaher Corporation Company Profile

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Danaher Corporation | Latest news

Analyst Sees Opportunity In Danaher Stock As Sentiment Improves - Danaher...

Danaher Corp DHR on Tuesday reported first-quarter 2025 sales of $5.74 billion, down 1%...

Benzinga - 4 days ago

BLCO or DHR: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical Services sector have probably already heard of...

Zacks - 4 days ago

Danaher (DHR) Exceeds Earnings Expectations in Q1 2025

Summary:\n Danaher Corporation's Q1 results exceeded expectations with strong bioprocessing and...

Guru Focus - 5 days ago

Danaher (DHR) Set to Announce Q1 Earnings with Decline in EPS and Revenue

Summary:\n Danaher (DHR) is set to release its Q1 earnings on April 22nd, with analysts forecasting...

Guru Focus - 6 days ago

Danaher Corporation (DHR): Among Top Stocks in Bill Gates’ Portfolio with Huge...

We recently published a list of Bill Gates’ 10 Stock Positions with Huge Upside Potential. In this...

Insider Monkey - 4 days ago

Danaher (DHR) Surpasses Q1 Revenue Expectations with Strong Bioprocessing Growth...

Danaher Corporation (DHR) has announced its first-quarter financial results, reporting a revenue of...

Guru Focus - 5 days ago

Danaher Corp (DHR) Q1 2025 Earnings Call Highlights: Strong Bioprocessing Growth...

\nRevenue: $5.7 billion in the first quarter, with core revenue flat year-over-year.Gross Profit...

Guru Focus - 5 days ago

Danaher Q1 Earnings Beat Estimates, Life Sciences Sales Down Y/Y

Danaher Corporation’s (DHR Quick QuoteDHR - Free Report) first-quarter 2025 adjusted earnings of...

Zacks - 6 days ago

Danaher (DHR) Surpasses Q1 Earnings Expectations

Key Highlights:\n Danaher (DHR) beats Q1 EPS expectations with $1.88, surpassing by $0.24. Revenue of $5.74 billion exceeds estimates, despite a slight...

Guru Focus - 5 days ago

Barclays lifts Danaher stock price target to $215 on tariff strategy By...

On Tuesday, Barclays analyst Luke Sergott increased the price target for Danaher Corporation...

Investingcom - 5 days ago